Kiora Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Name: Kiora Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Kiora Pharmaceuticals Inc
Rating: 1.73508325
Author: Trendlyne DVM scores

about

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, ...

2.68 -0.05 (-1.83%)

35.89% Fall from 52W High

19,441

XNAS Volume

XNAS 05 Sep, 2025 4:01 PM (EDT)

Not Eligible

Mid Valuation

31.8 / 100

Technically Neutral

37.6 / 100

1Yr Price target upside is 310%

2 analysts

Kiora Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kiora Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, ...

35.89% Fall from 52W High

SWOT Analysis

Kiora Pharmaceuticals Inc Live Price Chart